Science ❯ Medical Research ❯ Clinical Trials

Drug Efficacy

Neurological Disorders Health Outcomes Ivermectin Studies GLP-1 Receptor Agonists Cardiovascular Disease Research GLP-1 Injections Long-acting Treatments Neuroscience Alzheimer's Research Public Health

3 ARTICLES

last wk.

Daraxonrasib Doubles Survival for Treated Metastatic Pancreatic Cancer in Phase 3 Trial

Using cyclophilin A to disable mutant KRAS, the oral pill has triggered an FDA expanded‑access pathway as the maker prepares expedited approval filings.

9 ARTICLES

4w ago

Ivermectin Combo Prescriptions Jump After Mel Gibson Podcast, Study Finds

3 ARTICLES

2mo ago

Keytruda’s Price Faces New Scrutiny in Germany After Spending Tops €2 Billion

4 ARTICLES

4mo ago

Novo’s New GLP‑1 Pill Tests Lilly’s Lead as Investors Eye Pfizer’s Cheaper Shares

7 ARTICLES

8mo ago

Pfizer to Buy Metsera in Up to $7.3 Billion Obesity Bet

4 ARTICLES

9mo ago

Novartis Licenses Arrowhead’s RNAi Parkinson’s Drug in Deal Worth Up to $2.2 Billion

4 ARTICLES

10mo ago

NHS Weight-Loss Jab Prescriptions Near Three Million as Experts Raise Lifelong Use Concerns

7 ARTICLES

last yr.

Eli Lilly’s Lepodisiran Achieves 94% Reduction in Genetic Heart Disease Risk Factor in Phase 2 Trial

4 ARTICLES

last yr.

Nurse's Death Linked to NHS-Approved Weight-Loss Drug Mounjaro

10 ARTICLES

last yr.

Novo Nordisk Launches Wegovy in France Without Reimbursement

6 ARTICLES

last yr.

New HIV Drug Could Revolutionize Prevention at Just $40 Annually

Drug Efficacy

Daraxonrasib Doubles Survival for Treated Metastatic Pancreatic Cancer in Phase 3 Trial

Ivermectin Combo Prescriptions Jump After Mel Gibson Podcast, Study Finds

Keytruda’s Price Faces New Scrutiny in Germany After Spending Tops €2 Billion

Novo’s New GLP‑1 Pill Tests Lilly’s Lead as Investors Eye Pfizer’s Cheaper Shares

Pfizer to Buy Metsera in Up to $7.3 Billion Obesity Bet

Novartis Licenses Arrowhead’s RNAi Parkinson’s Drug in Deal Worth Up to $2.2 Billion

EU Regulator Recommends AstraZeneca’s Low-Carbon COPD Inhaler

B.C. Panel Confirms End to Brineura Funding for Batten Disease Treatment

FDA Approves Six-Month HIV Prevention Injection Lenacapavir

BC Discontinues Brineura Funding for 9-Year-Old with Batten Disease

Never miss stories about

Drug Efficacy

NICE Poised to Reject NHS Coverage for Breakthrough Alzheimer’s Drugs

NHS Weight-Loss Jab Prescriptions Near Three Million as Experts Raise Lifelong Use Concerns

Eli Lilly’s Lepodisiran Achieves 94% Reduction in Genetic Heart Disease Risk Factor in Phase 2 Trial

Nurse's Death Linked to NHS-Approved Weight-Loss Drug Mounjaro

Novo Nordisk Launches Wegovy in France Without Reimbursement

New HIV Drug Could Revolutionize Prevention at Just $40 Annually

Never miss stories about

Drug Efficacy